STEP study is a randomized investigator-initiated trial showing the superiority of polymer-based VCD (FemoSeal, Terumo) over suture-based VCD (Perclose ProGlide, Abbott) in achieving hemostasis at the femoral access site after lower limb arterial endovascular revascularization.

Listen to this interview with the study principal investigator, Prof Yann Gouëffic, who shares his insights from the data analysis and its implications to everyday clinical practice.